Schizophrenia medical marijuana

McGuire’s team has carried out two trials exploring the therapeutic potential of CBD in patients with schizophrenia. One of these, involving 88 patients, found a decreased rate of psychotic symptoms in those treated with CBD compared with placebo alongside their antipsychotic medicines, but a comparable adverse event rate between the two groups . Good research is the foundation that holds the cannabis industry together. After all, if science cannot prove cannabis&8217; place in the world of medicine, how can lawmakers impose less restrictive rules on the plant in order to let the industry prosper? Prospering it is, with the global medical cannabis market generating USD $26.1 billion across&8230; Cannabis use, particularly frequent use of high-THC cannabis, can cause a substance-induced psychosis in some people. This is not the same thing as having a “bad trip”, or a negative experience from being overly intoxicated. Substance-induced psychosis is a medical disorder where people can experience psychosis symptoms for up to a month, brought on by using cannabis or other substances. https://ontariomedicinalmarijuana.com/ follows heavy use of highly potent cannabis.